VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
AXS
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
AXSAXIS Capital Holdings Limited
$108.84$8.0B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksAXSQuarterly Financials

AXIS Capital Holdings Limited (AXS) Quarterly Financials

120+ quarters historyFree accessUpdated daily

AXIS Capital Holdings Limited (AXS) quarterly income statement — complete revenue, gross profit & net income history

AXS Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23
Revenue1.64B1.73B1.69B1.54B1.47B1.58B1.52B1.47B1.44B1.42B1.48B1.35B
Revenue Growth %11.98%9.44%11.42%4.72%1.69%11.97%2.44%8.69%7.92%3.31%8.56%7.22%
Medical Costs & Claims867.28M859.43M1.13B1.08B1.05B1.11B1.11B1.03B982.92M1.41B1.05B989.52M
Medical Cost Ratio %52.77%49.55%66.56%69.96%71.57%69.93%72.83%70.1%68.1%99.36%70.6%73.12%
Gross Profit776.35M875.01M566.2M462.65M417.3M476.54M412.94M439.77M460.52M9.12M436.16M363.75M
Gross Margin %47.23%50.45%33.44%30.04%28.43%30.07%27.17%29.9%31.9%0.64%29.4%26.88%
Gross Profit Growth %86.04%83.62%37.11%5.2%-9.39%5124.07%-5.32%20.9%19.14%-96.92%136.88%54.81%
Operating Expenses468.2M539.44M196.16M182.39M181.19M209.58M185.91M195.16M190.88M194.79M226.38M187.62M
OpEx / Revenue %28.49%31.1%11.59%11.84%12.34%13.22%12.23%13.27%13.22%13.76%15.26%13.86%
Depreciation & Amortization2.4M63.69M13.88M13.48M13.79M13.13M14.28M13.64M14.26M13.17M31.2M16.21M
Combined Ratio %81.25%80.65%78.15%81.8%83.91%83.15%85.06%83.37%81.32%113.12%85.86%86.98%
Operating Income308.14M335.57M370.03M280.26M236.1M266.96M227.03M244.61M269.64M-185.67M209.78M176.13M
Operating Margin %18.75%19.35%21.85%18.2%16.09%16.85%14.94%16.63%18.68%-13.12%14.14%13.02%
Operating Income Growth %30.51%25.7%62.99%14.57%-12.44%243.78%8.22%38.88%36.04%-335.39%9692.23%512.36%
EBITDA310.54M399.26M383.92M293.74M249.89M280.09M241.31M258.25M283.89M-172.49M240.98M192.34M
EBITDA Margin %18.89%23.02%22.67%19.07%17.03%17.67%15.88%17.56%19.67%-12.19%16.24%14.21%
Interest Expense16.43M16.84M16.66M16.59M16.57M16.76M16.85M17.01M17.15M18.34M16.45M16.74M
Non-Operating Income0-16.84M-16.66M-16.59M-16.57M-16.76M-16.85M-17.01M-17.15M-18.34M-16.45M-16.74M
Pretax Income308.14M335.57M372.12M279.56M238.39M274.22M228.65M252.51M270.81M-184.34M212.72M178.23M
Pretax Margin %18.75%19.35%21.98%18.15%16.24%17.3%15.05%17.17%18.76%-13.02%14.34%13.17%
Income Tax55.81M45.96M70.25M56.2M44.32M-19.41M47.92M40.55M-124.65M-41.76M24.62M27.56M
Effective Tax Rate %18.11%13.7%18.88%20.1%18.59%-7.08%20.96%16.06%-46.03%22.65%11.58%15.46%
Net Income254.77M289.61M301.86M223.36M194.07M293.63M180.73M211.96M395.46M-142.58M188.1M150.67M
Net Margin %15.5%16.7%17.83%14.5%13.22%18.53%11.89%14.41%27.4%-10.07%12.68%11.13%
Net Income Growth %31.28%-1.37%67.03%5.38%-50.93%305.95%-3.92%40.68%119.58%-394.03%2104.45%333.25%
EPS (Diluted)3.293.673.742.722.263.382.042.404.53-1.762.101.67
EPS Growth %45.58%8.58%83.33%13.33%-50.11%292.05%-2.86%43.71%125.37%-466.67%9867.44%421.88%
EPS (Basic)3.343.733.792.752.303.432.062.424.57-1.762.121.68
Diluted Shares Outstanding75.15M76.83M79.33M79.33M82.38M85.18M85M85.33M85.69M85.27M86.11M85.81M